There is a great deal of information that can be gained by examining a patient’s genetics. For example, genetic testing can assess a patient’s hereditary risk of Alzheimer’s disease. Genetic testing can also determine which medications are likely to be effective or ineffective for treatment.
Genetic Testing and Cancer
Know your carrier risk for inherited conditions
- Cancer Carrier Screening
- Alzheimer’s Disease
- Inherited Cardiomyopathy
Testing for genetic variants provides information to determine the most effective and efficient treatment plans. Contact the laboratory for the most up-to-date listing of available cancer screening targets.
Both early and late onset Alzheimer’s have a genetic component. Genetic testing can provide results to best determine treatment, psychosocial counseling and support programs.
This test can benefit patients with personal or family history that is suggestive of hereditary cardiomyopathy and patients with symptoms of cardiomyopathy, a heart muscle disease that makes it more difficult to pump blood around the body. Results of this testing can help guide treatment plans.
Altered metabolic activity of one or more major CYP enzymatic pathways is highly prevalent and contributes to variable patient medication responses. Improve the efficacy of patient treatment plans using Luxor’s Pharmacogenetic testing results and reduce risks and costs associated with ineffective and/or potentially harmful medications.
Knowledge about one’s predisposition to type II diabetes can allow for early intervention or lifestyle change, and can assist in prevention or management of the increasingly common disease.